Skip to contentMAZANET ROSEMARY — GTX INC /DE/ insider: 85 transactions · InsiderLensMAZANET ROSEMARY
- Director at GTX INC /DE/ · on record since Jan 4, 2006
- Director at Columbia Care Inc. · on record since Mar 26, 2024
- Director at AKSYS LTD · on record since Aug 10, 2006
- Director at Kairos Pharma, LTD. · on record since Sep 24, 2024
- Director at ACCESS PHARMACEUTICALS INC · on record since Jan 8, 2007
- former Director at Columbia Care Inc. · on record since Sep 26, 2025
- Chief Medical Officer at RXI PHARMACEUTICALS CORP · on record since Jun 19, 2012
- Director at Cactus Ventures, Inc. · on record since Jan 2, 2013
- Chief Scientific Officer at Columbia Care Inc. · on record since Feb 14, 2022
- Acting Chief Executive Officer at ACCESS PHARMACEUTICALS INC · on record since May 20, 2005
Insider trading activity of MAZANET ROSEMARY
- Transactions on record
- 85
- since Feb 6, 2004
- Open-market buys
- 1
- $395
- Open-market sells
- 0
- Companies traded
- 6
- last filing Apr 7, 2025
Figures computed from official regulatory filings — methodology.
Companies where MAZANET ROSEMARY has traded
Track record of MAZANET ROSEMARY
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of MAZANET ROSEMARY
Co-insiders of MAZANET ROSEMARY
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Adage Capital Management, L.P.ACCESS PHARMACEUTICALS INC
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Apr 7, 2025 | ExerciseD | -272,727 | 0.00 USD | $0 | SEC |
| Apr 7, 2025 | Exercise | 272,727 | — | — | SEC |
| Apr 2, 2025 | Exercise | 37,791 | — | — | SEC |
| Apr 2, 2025 | ExerciseD | -37,791 | 0.00 USD | $0 | SEC |
| Apr 2, 2025 | ExerciseD | -41,529 | 0.00 USD | $0 | SEC |
| Apr 2, 2025 | Exercise | 41,529 | — | — | SEC |
| Mar 24, 2025 | ExerciseD | -18,171 | 0.00 USD | $0 | SEC |
| Mar 24, 2025 | Exercise | 18,171 | — | — | SEC |
| Jun 24, 2024 | AwardD | 2,200 | 0.00 USD | $0 | SEC |
| Apr 25, 2024 | Award | 37,710 | — | — | SEC |
| Apr 8, 2024 | Exercise | 363,636 | — | — | SEC |
| Apr 8, 2024 | ExerciseD | -363,636 | 0.00 USD | $0 | SEC |
| Apr 2, 2024 | ExerciseD | -54,776 | 0.00 USD | $0 | SEC |
| Apr 2, 2024 | ExerciseD | -37,791 | 0.00 USD | $0 | SEC |
| Apr 2, 2024 | Exercise | 217,151 | — | — | SEC |
| Apr 2, 2024 | ExerciseD | -124,584 | 0.00 USD | $0 | SEC |
| Mar 26, 2024 | ExerciseD | -18,171 | 0.00 USD | $0 | SEC |
| Mar 26, 2024 | Exercise | 18,171 | — | — | SEC |
| Aug 9, 2023 | AwardD | 909,091 | 0.00 USD | $0 | SEC |
| Jul 7, 2023 | ExerciseD | -19,032 | 0.00 USD | $0 | SEC |
| Jul 7, 2023 | Other | -4,441 | 0.48 USD | $2.1K | SEC |
| Jul 7, 2023 | Exercise | 19,032 | — | — | SEC |
| Jun 30, 2023 | AwardD | 25,000 | 0.00 USD | $0 | SEC |
| May 5, 2023 | Exercise | 37,790 | — | — | SEC |
| May 5, 2023 | ExerciseD | -54,775 | — | — | SEC |